Listed

BIO-TECHNE Corp

TECHNasdaqCIK 842023HealthcareFiscal year ends Jun 30

Latest reported revenue, Q4 FY2026$321.2mRevenue, Q4 FY2026, three months to 2026-06-30$321.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-08-24, accession 0001104659-26-100322. Derived: 12-month figure less the 9-month figure.Report this figureThree months to Jun 30, 2026, from the 10-K filed Aug 24, 2026.

Latest quarter: Q4 FY2026

Three months to Jun 30, 2026, against the same quarter a year earlier.

  • Revenue$321.2mRevenue, Q4 FY2026, three months to 2026-06-30$321.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-08-24, accession 0001104659-26-100322. Derived: 12-month figure less the 9-month figure.Report this figure+1.3% on a year earlier
  • Gross margin65.8%Gross margin, Q4 FY2026, three months to 2026-06-30. gross profit / revenueGross profit: $211.4m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-08-24, accession 0001104659-26-100322. Derived: 12-month figure less the 9-month figure.Revenue: $321.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-08-24, accession 0001104659-26-100322. Derived: 12-month figure less the 9-month figure.Report this figure+3.1 pts on a year earlier
  • Operating margin23.1%Operating margin, Q4 FY2026, three months to 2026-06-30. operating income / revenueOperating income: $74.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-08-24, accession 0001104659-26-100322. Derived: 12-month figure less the 9-month figure.Revenue: $321.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-08-24, accession 0001104659-26-100322. Derived: 12-month figure less the 9-month figure.Report this figure+30.7 pts on a year earlier
  • Net margin17.0%Net margin, Q4 FY2026, three months to 2026-06-30. net income / revenueNet income: $54.6m. XBRL concept us-gaap:ProfitLoss. 10-K filed 2026-08-24, accession 0001104659-26-100322. Derived: 12-month figure less the 9-month figure.Revenue: $321.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-08-24, accession 0001104659-26-100322. Derived: 12-month figure less the 9-month figure.Report this figure+22.6 pts on a year earlier
  • Diluted EPSnot reported (Diluted EPS not reported)No year-earlier figure to compare
  • Free cash flow$86.9mFree cash flow, Q4 FY2026, three months to 2026-06-30. operating cash flow − capital expenditureOperating cash flow: $95.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-08-24, accession 0001104659-26-100322. Derived: 12-month figure less the 9-month figure.Capital expenditure: $8.5m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-08-24, accession 0001104659-26-100322. Derived: 12-month figure less the 9-month figure.Report this figure−6.8% on a year earlier

Last eight quarters

Full statements
Revenue$321.2mGross margin 65.8%
Diluted EPS$0.32, Q3 FY2026
Free cash flow$86.9m, Q4 FY2026
BIO-TECHNE Corp, key figures for the last eight quarters
Line itemUnitQ1 FY20252024-09-30Q2 FY20252024-12-31Q3 FY20252025-03-31Q4 FY20252025-06-30Q1 FY20262025-09-30Q2 FY20262025-12-31Q3 FY20262026-03-31Q4 FY20262026-06-30Shape over the periods
Revenue$m289Revenue, Q1 FY2025, three months to 2024-09-30$289.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-05, accession 0001104659-25-107053.Report this figure297Revenue, Q2 FY2025, three months to 2024-12-31$297.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-02-04, accession 0001104659-26-010335.Report this figure316Revenue, Q3 FY2025, three months to 2025-03-31$316.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-06, accession 0001104659-26-056302.Report this figure317Revenue, Q4 FY2025, three months to 2025-06-30$317.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-08-24, accession 0001104659-26-100322. Derived: 12-month figure less the 9-month figure.Report this figure287Revenue, Q1 FY2026, three months to 2025-09-30$286.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-05, accession 0001104659-25-107053.Report this figure296Revenue, Q2 FY2026, three months to 2025-12-31$295.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-02-04, accession 0001104659-26-010335.Report this figure311Revenue, Q3 FY2026, three months to 2026-03-31$311.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-06, accession 0001104659-26-056302.Report this figure321Revenue, Q4 FY2026, three months to 2026-06-30$321.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-08-24, accession 0001104659-26-100322. Derived: 12-month figure less the 9-month figure.Report this figure
Gross margin%63.2%Gross margin, Q1 FY2025, three months to 2024-09-30. gross profit / revenueGross profit: $183.0m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-05, accession 0001104659-25-107053.Revenue: $289.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-05, accession 0001104659-25-107053.Report this figure65.3%Gross margin, Q2 FY2025, three months to 2024-12-31. gross profit / revenueGross profit: $193.9m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-02-04, accession 0001104659-26-010335.Revenue: $297.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-02-04, accession 0001104659-26-010335.Report this figure67.9%Gross margin, Q3 FY2025, three months to 2025-03-31. gross profit / revenueGross profit: $214.6m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-06, accession 0001104659-26-056302.Revenue: $316.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-06, accession 0001104659-26-056302.Report this figure62.7%Gross margin, Q4 FY2025, three months to 2025-06-30. gross profit / revenueGross profit: $198.8m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-08-24, accession 0001104659-26-100322. Derived: 12-month figure less the 9-month figure.Revenue: $317.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-08-24, accession 0001104659-26-100322. Derived: 12-month figure less the 9-month figure.Report this figure65.6%Gross margin, Q1 FY2026, three months to 2025-09-30. gross profit / revenueGross profit: $188.1m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-05, accession 0001104659-25-107053.Revenue: $286.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-05, accession 0001104659-25-107053.Report this figure64.6%Gross margin, Q2 FY2026, three months to 2025-12-31. gross profit / revenueGross profit: $191.3m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-02-04, accession 0001104659-26-010335.Revenue: $295.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-02-04, accession 0001104659-26-010335.Report this figure66.9%Gross margin, Q3 FY2026, three months to 2026-03-31. gross profit / revenueGross profit: $208.3m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-06, accession 0001104659-26-056302.Revenue: $311.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-06, accession 0001104659-26-056302.Report this figure65.8%Gross margin, Q4 FY2026, three months to 2026-06-30. gross profit / revenueGross profit: $211.4m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-08-24, accession 0001104659-26-100322. Derived: 12-month figure less the 9-month figure.Revenue: $321.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-08-24, accession 0001104659-26-100322. Derived: 12-month figure less the 9-month figure.Report this figure
Operating margin%13.8%Operating margin, Q1 FY2025, three months to 2024-09-30. operating income / revenueOperating income: $40.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-05, accession 0001104659-25-107053.Revenue: $289.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-05, accession 0001104659-25-107053.Report this figure16.0%Operating margin, Q2 FY2025, three months to 2024-12-31. operating income / revenueOperating income: $47.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-02-04, accession 0001104659-26-010335.Revenue: $297.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-02-04, accession 0001104659-26-010335.Report this figure12.2%Operating margin, Q3 FY2025, three months to 2025-03-31. operating income / revenueOperating income: $38.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-06, accession 0001104659-26-056302.Revenue: $316.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-06, accession 0001104659-26-056302.Report this figure(7.5%)Operating margin, Q4 FY2025, three months to 2025-06-30. operating income / revenueOperating income: −$23.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-08-24, accession 0001104659-26-100322. Derived: 12-month figure less the 9-month figure.Revenue: $317.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-08-24, accession 0001104659-26-100322. Derived: 12-month figure less the 9-month figure.Report this figure16.6%Operating margin, Q1 FY2026, three months to 2025-09-30. operating income / revenueOperating income: $47.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-05, accession 0001104659-25-107053.Revenue: $286.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-05, accession 0001104659-25-107053.Report this figure18.4%Operating margin, Q2 FY2026, three months to 2025-12-31. operating income / revenueOperating income: $54.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-02-04, accession 0001104659-26-010335.Revenue: $295.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-02-04, accession 0001104659-26-010335.Report this figure24.2%Operating margin, Q3 FY2026, three months to 2026-03-31. operating income / revenueOperating income: $75.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-06, accession 0001104659-26-056302.Revenue: $311.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-06, accession 0001104659-26-056302.Report this figure23.1%Operating margin, Q4 FY2026, three months to 2026-06-30. operating income / revenueOperating income: $74.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-08-24, accession 0001104659-26-100322. Derived: 12-month figure less the 9-month figure.Revenue: $321.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-08-24, accession 0001104659-26-100322. Derived: 12-month figure less the 9-month figure.Report this figure
Net margin%11.6%Net margin, Q1 FY2025, three months to 2024-09-30. net income / revenueNet income: $33.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-05, accession 0001104659-25-107053.Revenue: $289.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-05, accession 0001104659-25-107053.Report this figure11.7%Net margin, Q2 FY2025, three months to 2024-12-31. net income / revenueNet income: $34.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-02-04, accession 0001104659-26-010335.Revenue: $297.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-02-04, accession 0001104659-26-010335.Report this figure7.1%Net margin, Q3 FY2025, three months to 2025-03-31. net income / revenueNet income: $22.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-06, accession 0001104659-26-056302.Revenue: $316.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-06, accession 0001104659-26-056302.Report this figure(5.6%)Net margin, Q4 FY2025, three months to 2025-06-30. net income / revenueNet income: −$17.7m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-08-22, accession 0001558370-25-011716. Derived: 12-month figure less the 9-month figure.Revenue: $317.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-08-24, accession 0001104659-26-100322. Derived: 12-month figure less the 9-month figure.Report this figure13.3%Net margin, Q1 FY2026, three months to 2025-09-30. net income / revenueNet income: $38.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-05, accession 0001104659-25-107053.Revenue: $286.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-05, accession 0001104659-25-107053.Report this figure12.8%Net margin, Q2 FY2026, three months to 2025-12-31. net income / revenueNet income: $38.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-02-04, accession 0001104659-26-010335.Revenue: $295.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-02-04, accession 0001104659-26-010335.Report this figure16.4%Net margin, Q3 FY2026, three months to 2026-03-31. net income / revenueNet income: $51.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-06, accession 0001104659-26-056302.Revenue: $311.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-06, accession 0001104659-26-056302.Report this figure17.0%Net margin, Q4 FY2026, three months to 2026-06-30. net income / revenueNet income: $54.6m. XBRL concept us-gaap:ProfitLoss. 10-K filed 2026-08-24, accession 0001104659-26-100322. Derived: 12-month figure less the 9-month figure.Revenue: $321.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-08-24, accession 0001104659-26-100322. Derived: 12-month figure less the 9-month figure.Report this figure
Diluted EPS$ per share0.21Diluted EPS, Q1 FY2025, three months to 2024-09-30$0.21 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-05, accession 0001104659-25-107053.Report this figure0.22Diluted EPS, Q2 FY2025, three months to 2024-12-31$0.22 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-02-04, accession 0001104659-26-010335.Report this figure0.14Diluted EPS, Q3 FY2025, three months to 2025-03-31$0.14 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-06, accession 0001104659-26-056302.Report this figurenot reported (Diluted EPS not reported)0.24Diluted EPS, Q1 FY2026, three months to 2025-09-30$0.24 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-05, accession 0001104659-25-107053.Report this figure0.24Diluted EPS, Q2 FY2026, three months to 2025-12-31$0.24 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-02-04, accession 0001104659-26-010335.Report this figure0.32Diluted EPS, Q3 FY2026, three months to 2026-03-31$0.32 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-06, accession 0001104659-26-056302.Report this figurenot reported (Diluted EPS not reported)
Free cash flow$m54.7Free cash flow, Q1 FY2025, three months to 2024-09-30. operating cash flow − capital expenditureOperating cash flow: $63.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-05, accession 0001104659-25-107053.Capital expenditure: $9.2m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-05, accession 0001104659-25-107053.Report this figure77.5Free cash flow, Q2 FY2025, three months to 2024-12-31. operating cash flow − capital expenditureOperating cash flow: $84.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-02-04, accession 0001104659-26-010335. Derived: 6-month figure less the 3-month figure.Capital expenditure: $6.8m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-02-04, accession 0001104659-26-010335. Derived: 6-month figure less the 3-month figure.Report this figure31.0Free cash flow, Q3 FY2025, three months to 2025-03-31. operating cash flow − capital expenditureOperating cash flow: $41.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-06, accession 0001104659-26-056302. Derived: 9-month figure less the 6-month figure.Capital expenditure: $10.1m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-06, accession 0001104659-26-056302. Derived: 9-month figure less the 6-month figure.Report this figure93.3Free cash flow, Q4 FY2025, three months to 2025-06-30. operating cash flow − capital expenditureOperating cash flow: $98.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-08-24, accession 0001104659-26-100322. Derived: 12-month figure less the 9-month figure.Capital expenditure: $4.9m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-08-24, accession 0001104659-26-100322. Derived: 12-month figure less the 9-month figure.Report this figure22.2Free cash flow, Q1 FY2026, three months to 2025-09-30. operating cash flow − capital expenditureOperating cash flow: $27.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-05, accession 0001104659-25-107053.Capital expenditure: $5.4m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-05, accession 0001104659-25-107053.Report this figure76.5Free cash flow, Q2 FY2026, three months to 2025-12-31. operating cash flow − capital expenditureOperating cash flow: $82.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-02-04, accession 0001104659-26-010335. Derived: 6-month figure less the 3-month figure.Capital expenditure: $5.9m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-02-04, accession 0001104659-26-010335. Derived: 6-month figure less the 3-month figure.Report this figure77.6Free cash flow, Q3 FY2026, three months to 2026-03-31. operating cash flow − capital expenditureOperating cash flow: $86.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-06, accession 0001104659-26-056302. Derived: 9-month figure less the 6-month figure.Capital expenditure: $9.1m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-06, accession 0001104659-26-056302. Derived: 9-month figure less the 6-month figure.Report this figure86.9Free cash flow, Q4 FY2026, three months to 2026-06-30. operating cash flow − capital expenditureOperating cash flow: $95.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-08-24, accession 0001104659-26-100322. Derived: 12-month figure less the 9-month figure.Capital expenditure: $8.5m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-08-24, accession 0001104659-26-100322. Derived: 12-month figure less the 9-month figure.Report this figure

Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.

Last five fiscal years

Revenue$1.22bnGross margin 65.8%
Diluted EPS$1.16, FY2026
Free cash flow$263.2m, FY2026
BIO-TECHNE Corp, key figures for the last five fiscal years
Line itemUnitFY20222022-06-30FY20232023-06-30FY20242024-06-30FY20252025-06-30FY20262026-06-30Shape over the periods
Revenue$m1,106Revenue, FY2022, twelve months to 2022-06-30$1.11bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-08-22, accession 0001558370-24-012430.Report this figure1,137Revenue, FY2023, twelve months to 2023-06-30$1.14bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-08-22, accession 0001558370-25-011716.Report this figure1,159Revenue, FY2024, twelve months to 2024-06-30$1.16bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-08-24, accession 0001104659-26-100322.Report this figure1,220Revenue, FY2025, twelve months to 2025-06-30$1.22bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-08-24, accession 0001104659-26-100322.Report this figure1,215Revenue, FY2026, twelve months to 2026-06-30$1.22bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-08-24, accession 0001104659-26-100322.Report this figure
Gross margin%68.4%Gross margin, FY2022, twelve months to 2022-06-30. gross profit / revenueGross profit: $756.5m. XBRL concept us-gaap:GrossProfit. 10-K filed 2024-08-22, accession 0001558370-24-012430.Revenue: $1.11bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-08-22, accession 0001558370-24-012430.Report this figure67.7%Gross margin, FY2023, twelve months to 2023-06-30. gross profit / revenueGross profit: $769.8m. XBRL concept us-gaap:GrossProfit. 10-K filed 2025-08-22, accession 0001558370-25-011716.Revenue: $1.14bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-08-22, accession 0001558370-25-011716.Report this figure66.4%Gross margin, FY2024, twelve months to 2024-06-30. gross profit / revenueGross profit: $769.7m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-08-24, accession 0001104659-26-100322.Revenue: $1.16bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-08-24, accession 0001104659-26-100322.Report this figure64.8%Gross margin, FY2025, twelve months to 2025-06-30. gross profit / revenueGross profit: $790.3m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-08-24, accession 0001104659-26-100322.Revenue: $1.22bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-08-24, accession 0001104659-26-100322.Report this figure65.8%Gross margin, FY2026, twelve months to 2026-06-30. gross profit / revenueGross profit: $799.1m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-08-24, accession 0001104659-26-100322.Revenue: $1.22bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-08-24, accession 0001104659-26-100322.Report this figure
Operating margin%26.8%Operating margin, FY2022, twelve months to 2022-06-30. operating income / revenueOperating income: $296.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2024-08-22, accession 0001558370-24-012430.Revenue: $1.11bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-08-22, accession 0001558370-24-012430.Report this figure26.3%Operating margin, FY2023, twelve months to 2023-06-30. operating income / revenueOperating income: $298.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-08-22, accession 0001558370-25-011716.Revenue: $1.14bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-08-22, accession 0001558370-25-011716.Report this figure17.8%Operating margin, FY2024, twelve months to 2024-06-30. operating income / revenueOperating income: $206.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-08-24, accession 0001104659-26-100322.Revenue: $1.16bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-08-24, accession 0001104659-26-100322.Report this figure8.4%Operating margin, FY2025, twelve months to 2025-06-30. operating income / revenueOperating income: $102.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-08-24, accession 0001104659-26-100322.Revenue: $1.22bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-08-24, accession 0001104659-26-100322.Report this figure20.7%Operating margin, FY2026, twelve months to 2026-06-30. operating income / revenueOperating income: $251.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-08-24, accession 0001104659-26-100322.Revenue: $1.22bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-08-24, accession 0001104659-26-100322.Report this figure
Net margin%24.6%Net margin, FY2022, twelve months to 2022-06-30. net income / revenueNet income: $272.1m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2024-08-22, accession 0001558370-24-012430.Revenue: $1.11bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-08-22, accession 0001558370-24-012430.Report this figure25.1%Net margin, FY2023, twelve months to 2023-06-30. net income / revenueNet income: $285.3m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-08-22, accession 0001558370-25-011716.Revenue: $1.14bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-08-22, accession 0001558370-25-011716.Report this figure14.5%Net margin, FY2024, twelve months to 2024-06-30. net income / revenueNet income: $168.1m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-08-22, accession 0001558370-25-011716.Revenue: $1.16bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-08-24, accession 0001104659-26-100322.Report this figure6.0%Net margin, FY2025, twelve months to 2025-06-30. net income / revenueNet income: $73.4m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-08-22, accession 0001558370-25-011716.Revenue: $1.22bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-08-24, accession 0001104659-26-100322.Report this figure15.0%Net margin, FY2026, twelve months to 2026-06-30. net income / revenueNet income: $181.9m. XBRL concept us-gaap:ProfitLoss. 10-K filed 2026-08-24, accession 0001104659-26-100322.Revenue: $1.22bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-08-24, accession 0001104659-26-100322.Report this figure
Diluted EPS$ per share1.66Diluted EPS, FY2022, twelve months to 2022-06-30$1.66 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2024-08-22, accession 0001558370-24-012430.Report this figure1.76Diluted EPS, FY2023, twelve months to 2023-06-30$1.76 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2025-08-22, accession 0001558370-25-011716.Report this figure1.05Diluted EPS, FY2024, twelve months to 2024-06-30$1.05 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-08-24, accession 0001104659-26-100322.Report this figure0.46Diluted EPS, FY2025, twelve months to 2025-06-30$0.46 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-08-24, accession 0001104659-26-100322.Report this figure1.16Diluted EPS, FY2026, twelve months to 2026-06-30$1.16 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-08-24, accession 0001104659-26-100322.Report this figure
Free cash flow$m280Free cash flow, FY2022, twelve months to 2022-06-30. operating cash flow − capital expenditureOperating cash flow: $325.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2024-08-22, accession 0001558370-24-012430.Capital expenditure: $44.9m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2024-08-22, accession 0001558370-24-012430.Report this figure216Free cash flow, FY2023, twelve months to 2023-06-30. operating cash flow − capital expenditureOperating cash flow: $254.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-08-22, accession 0001558370-25-011716.Capital expenditure: $38.2m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-08-22, accession 0001558370-25-011716.Report this figure236Free cash flow, FY2024, twelve months to 2024-06-30. operating cash flow − capital expenditureOperating cash flow: $299.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-08-24, accession 0001104659-26-100322.Capital expenditure: $62.9m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-08-24, accession 0001104659-26-100322.Report this figure257Free cash flow, FY2025, twelve months to 2025-06-30. operating cash flow − capital expenditureOperating cash flow: $287.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-08-24, accession 0001104659-26-100322.Capital expenditure: $31.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-08-24, accession 0001104659-26-100322.Report this figure263Free cash flow, FY2026, twelve months to 2026-06-30. operating cash flow − capital expenditureOperating cash flow: $292.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-08-24, accession 0001104659-26-100322.Capital expenditure: $28.9m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-08-24, accession 0001104659-26-100322.Report this figure

Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.

Insider purchases and sales

All insider transactions

The last 20 open-market transactions reported on Form 4 (codes P and S). The reported price is the price per share the insider stated on the form: filing data, not a market price.

No open-market purchases or sales by insiders are in coverage from Nov 2024 to Oct 2026.

No open-market purchases or sales by insiders are in coverage for this company.

Funds that report holding it

All funds

From each manager's latest Form 13F, largest reported value first. Reported value is as filed at the quarter end: filing data, not a price. A put or call is an option position, not shares held.

Funds that report holding BIO-TECHNE Corp
FundQuarter endedReported valueSharesPut or callChange on the quarter before
BlackRock, Inc.2026-06-30$990.9m14,025,816Added+1,761,303
FMR LLC2026-06-30$904.0m12,794,784Added+4,894,856
VANGUARD CAPITAL MANAGEMENT LLC2026-06-30$721.9m10,218,558Added+38,849
GOLDMAN SACHS GROUP INC2026-06-30$518.8m7,343,324Added+5,399,790
HBK INVESTMENTS L P2026-06-30$482.2m6,825,000New+6,825,000
VANGUARD PORTFOLIO MANAGEMENT LLC2026-06-30$459.7m6,506,360Added+26,023
MORGAN STANLEY2026-06-30$450.4m6,374,717Reduced−2,158,156
STATE STREET CORP2026-06-30$422.5m5,980,370Added+111,974
GEODE CAPITAL MANAGEMENT, LLC2026-06-30$377.5m5,351,464Added+239,044
Invesco Ltd.2026-06-30$352.3m4,986,424Added+397,718

Recent filings

All 957 filings

Reports and events: 10-K, 10-Q, 8-K, proxy statements and ownership schedules.

BIO-TECHNE Corp, recent filings
FiledFormWhat it isAccession number
2026-09-2317:08 ET8-K5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001140361-26-037450
2026-09-1416:46 ET8-K8.01 Other events0001140361-26-036499
2026-08-2416:31 ET10-KAnnual reportPeriod 2026-06-300001104659-26-100322
2026-08-1206:30 ET8-K2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits0001104659-26-094391
2026-06-2618:49 ET8-K1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001999371-26-013527
2026-06-2508:21 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001999371-26-013429
2026-05-0616:31 ET10-QQuarterly reportPeriod 2026-03-310001104659-26-056302
2026-05-0606:30 ET8-K2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits0001104659-26-055887
2026-02-1116:30 ET8-K5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits0001104659-26-013412
2026-02-0416:31 ET10-QQuarterly reportPeriod 2025-12-310001104659-26-010335

Latest annual report

Form 10-K for the fiscal year ended Jun 30, 2026Filed Aug 24, 2026. Its page lists the documents and the extracted sections, such as Business and Risk factors.

Forecast league

Q1 FY2027, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by [object Promise].Forecast this quarter

About the filer

CIK
842023
Tickers
TECH
Exchange
Nasdaq
SIC code
2836 Biological Products, (No Diagnostic Substances)
Sector
Healthcare
Fiscal year ends
Jun 30
Incorporated in
MN
Filer category
Large accelerated filer
Former names
TECHNE CORP /MN/ (to 2014-10-28)

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:25 ET. Listed shows no prices and gives no investment advice.